GlassScriptPhysician profile
Lisa L Spillman
NPI 1790788420
$1,125.80
in general payments reported to CMS, 2019-2025
16 companies · $406 in 2025
The $406 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $180 · 2022: $162 · 2023: $168 · 2024: $210 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $783.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $246.59 | 2021-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $155.62 | 2021-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $123.38 | 2025 | Qelbree |
| Collegium Pharmaceutical, INC. | $107.04 | 2025 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $88.99 | 2021 | |
| Neurelis, INC. | $76.56 | 2022-2023 | Valtoco |
| Abbott Laboratories | $59.29 | 2024 | Cardiomems |
| Merck Sharp & Dohme LLC | $54.87 | 2021-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Glaxosmithkline, LLC. | $50.61 | 2022-2025 | Bexsero, Rotarix, Penmenvy |
| Biomarin Pharmaceutical INC. | $39.41 | 2022-2024 | Voxzogo 1.2mg |
| Boston Scientific Corporation | $33.85 | 2025 | Emblem Mri S-Icd, General - Thrombectomy |
| Verrica Pharmaceuticals INC. | $23.86 | 2024 | Ycanth |
| Xeris Pharmaceuticals, INC. | $19.71 | 2025 | Gvoke Hypopen |
| Sanofi Pasteur INC. | $17.52 | 2023 | |
| Sobi, INC | $16.70 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $11.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Spillman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.